Immune checkpoint inhibitor therapy

Cancer and autoimmunity can be viewed as differing consequences of deranged immune responses. The overexpression of certain molecules could result in development of cancer (failure of the immune system to control tumor cell growth), whereas oversuppression of the same molecules could lead to autoimmunity (failure of the immune system to regulate autoreactive responses). Hence, finely balanced immune surveillance against cancer and autoimmunity is critical.